Hi TP
We all do our own thing our own way.
and we all have to balance our portfolios/risk
My earlier post was made somewhat tongue in cheek.
For me SRX has something that cannot be quantified in a normal balanced sheet.
That is:
CREDIBILITY & ACCEPTANCE by the medical profession.
The lead times for biotech companies to gain credibility and acceptance is very long, but right now SRX have achieved both, and they are gaining real traction.
So realistically, for the foreseeable future things will continue to get better for SRX
Put simply, I believe the price will trend upwards.
Of course the share price itself will be subject to buying/selling pressure and will fluctuate.
One could put in downside/ upside potential prices to account for risk...... (risk/reward)
And we have all seen some of these figures quoted.
I think medium term, the upside potential is far greater than the downside risk.
Anyway its a win/win for all SRX holders
Cheers
Bendigo
- Forums
- ASX - By Stock
- SRX
- Mootley Fool goes out there
Mootley Fool goes out there, page-10
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $65.79M |
Open | High | Low | Value | Volume |
15.0¢ | 15.5¢ | 15.0¢ | $58.71K | 378.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 2627800 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 79966 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 2627800 | 0.150 |
4 | 991379 | 0.145 |
1 | 60000 | 0.140 |
1 | 40000 | 0.135 |
1 | 153846 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 79966 | 7 |
0.160 | 2398783 | 19 |
0.165 | 296786 | 10 |
0.170 | 99369 | 3 |
0.175 | 265000 | 2 |
Last trade - 12.34pm 10/07/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online